These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7439345)

  • 1. First FDA medical device regulations will affect development of many experimental contraceptives.
    Fam Plann Perspect; 1980; 12(4):212-3. PubMed ID: 7439345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health device legislation: an overview of the law and its impact on respiratory care.
    Bancroft ML; Steen JA
    Respir Care; 1978 Dec; 23(12):1179-84. PubMed ID: 10315033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive development and testing in the United States of America.
    Edelman DA; Van Os WA
    Int J Fertil; 1990; 35(4):206-10. PubMed ID: 1977711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical device reporting--FDA. Final rule.
    Fed Regist; 1984 Sep; 49(180):36326-51. PubMed ID: 10267669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration--FDA. Tentative final rule.
    Fed Regist; 1991 Nov; 56(228):60024-39. PubMed ID: 10115705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments.
    Fed Regist; 1993 Aug; 58(156):43451-5. PubMed ID: 10171508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; intent to initiate proceedings to establish effective dates of requirement for premarket approval for 31 class III preamendments devices--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1989 Jan; 54(4):550-2. PubMed ID: 10291347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical device reporting--FDA. Reproposal.
    Fed Regist; 1983 May; 48(104):24014-24. PubMed ID: 10261480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Jul; 63(146):40673-7. PubMed ID: 10181520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and drug administration guidance sections. A new paradigm for medical devices. Committee for Clinical Review. FDA.
    Watson JT
    ASAIO J; 1994; 40(2):138-44. PubMed ID: 8003750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical device review at the Food and Drug Administration: lessons from magnetic resonance spectroscopy and biliary lithotripsy.
    Makow LS
    Stanford Law Rev; 1994 Feb; 46(3):709-46. PubMed ID: 10171820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.